Potential Abiomed Class Action

October 10, 2013

Important Information

ClassAction.org is no longer reviewing claims for this case. The information here is for reference only. Up-to-date information and resources can be found here.

Comments |

At A Glance

This Alert Affects
Investors who purchased Abiomed common stock.
These investors may have legal recourse to pursue compensation for damages in light of a recent company disclosure.
Abiomed, Inc.
Additional Details
Abiomed is a leading healthcare technology company which has focused itself on developing new technologies to help or replace the pumping function of the heart.
On Nov. 1, 2012, Abiomed issued a press release announcing that the U.S. Attorney's Office for the District of Columbia was investigating the company's marketing and labeling of its Impella 2.5 heart pump system.